A Morpholino oligo can modify splicing of a pre-mRNA - www.gene-tools.com


AP2-dependent signals from the ectoderm regulate craniofacial development in the zebrafish embryo
Robert D. Knight, Yashar Javidan, Tailin Zhang, Sarah Nelson, Thomas F. Schilling


AP2 transcription factors regulate many aspects of embryonic development. Studies of AP2a (Tfap2a) function in mice and zebrafish have demonstrated a role in patterning mesenchymal cells of neural crest origin that form the craniofacial skeleton, while the mammalian Tfap2b is required in both the facial skeleton and kidney. Here, we show essential functions for zebrafish tfap2a and tfap2b in development of the facial ectoderm, and for signals from this epithelium that induce skeletogenesis in neural crest cells (NCCs). Zebrafish embryos deficient for both tfap2a and tfap2b show defects in epidermal cell survival and lack NCC-derived cartilages. We show that cartilage defects arise after NCC migration during skeletal differentiation, and that they can be rescued by transplantation of wild-type ectoderm. We propose a model in which AP2 proteins play two distinct roles in cranial NCCs: an early cell-autonomous function in cell specification and survival, and a later non-autonomous function regulating ectodermal signals that induce skeletogenesis


Vertebrate neural crest cells (NCCs) form all body pigmentation, peripheral neurons and glia, and most skull cartilage and bone. Some skeletogenic NCCs surround the brain to form the skull vault, while others migrate into the pharyngeal arches to form the jaw and larynx, and defects in these cells underlie many craniofacial birth defects. Cranial NCCs carry positional information from their origins alongside the midbrain and hindbrain, but also receive inductive signals from surrounding epithelia that determine skeletal fates (Graham, 2003; Santagati and Rijli, 2003; Trainor et al., 2003). Molecular mechanisms underlying these epithelial-mesenchymal interactions between NCCs and facial endoderm or ectoderm are largely unknown.

AP2 transcription factors are highly conserved DNA-binding proteins implicated in cranial NCC development. Three of the five members of this family in mammals (Tcfap2a, Tcfap2b and Tcfap2g) are expressed in migrating NCCs (Moser et al., 1995; Hilger-Eversheim et al., 2000). Tcfap2a-/- mutant mice have defects in the neural tube, body wall and limbs, and striking malformations of NCC-derived craniofacial structures (palate and ear ossicles) that correlate with defects in NCC survival (Schorle et al., 1996; Zhang et al., 1996; Morris-Kay et al., 1996). Craniofacial defects, however, could be indirectly due to disruptions in neural tube and epithelial morphogenesis in Tcfap2a-/- mutants, because early NCC migration appears grossly unaffected (Schorle et al., 1996). Tcfap2b-/- mutant mice and TFAP2B+/- humans have renal epithelial apoptosis and patent ductus arteriosus (Char syndrome), and mild defects in the NCC-derived craniofacial skeleton (Chazaud et al., 1996; Moser et al., 1997b; Satoda et al., 2000). The only defects reported in Tcfap2g-/- mutant mice are placental (Auman et al., 2002). Thus, co-expression and conserved protein structures of Tcfap2a and Tcfap2b suggest that their functions are redundant, but specific requirements in NCCs remain unclear.

Insights into tfap2a function in NCCs have come from analysis of the zebrafish lockjaw (lowts213) mutation, which eliminates tfap2a function but lacks the severe neural tube defects seen in Tcfap2a-/- mice. lowts213 mutants have early defects in NCC specification, prior to migration, and later lack subsets of cartilage and pigment cells (Schilling et al., 1996; Knight et al., 2003). low/tfap2a is required for kit expression in pigment cell precursors and differentiation of early melanocytes and iridophores (Knight et al., 2004), and previous studies of the mammalian KIT promoter suggests that this regulation is direct (Huang et al., 1998). Similar to studies of the Hoxa2 promoter in mice (Maconochie et al., 1999), zebrafish low/tfap2a is required to activate transcription of Hox group 2 genes in NCCs of the second pharyngeal arch (hyoid), suggesting that tfap2a regulates the segmental identities of NCCs (Knight et al., 2004). Hyoid defects and fusions with the mandibular arch in low mutants also resemble embryos lacking hoxa2/hoxb2 gene functions (Hunter and Prince, 2002). These studies demonstrate a cell-autonomous role for tfap2a in subsets of NCC, but cannot account for more widespread defects in NCC survival and chondrogenesis in AP2-deficient embryos (Schorle et al., 1996; Knight et al., 2003; Barrallo-Gimeno et al., 2004). Thus, Tcfap2a may have additional, non-autonomous roles in the tissues with which NCCs interact.

Tcfap2a was previously known as keratin transcription factor, KTF-1, a regulator of epidermal differentiation in vitro (Leask et al., 2001). Tcfap2a-/- mutant mice and zebrafish have normal skin architecture, suggesting that other AP2 family members can compensate in vivo. However, this has not been carefully examined in facial ectoderm, where specialized domains of pharyngeal ectoderm interact with NCCs in a similar way to the apical ectoderm of the limb bud, and these may depend on AP2 (Wall and Hogan, 1995; Hu and Helms, 1999). The pharyngeal ectoderm induces cartilage in mammals (Hall, 1980) and expresses signaling molecules (e.g. Fgf8, Shh, Bmp4) involved in craniofacial development. Fgf8 from the oral ectoderm patterns the mouse mandible (Trumpp et al., 1999; Tucker et al., 1999; Abu-Issa et al., 2002; Macatee et al., 2003), while Fgf4, Fgf9, Fgf17 and Fgf18 from pharyngeal ectoderm pattern other bones and teeth (Kettunen and Thesleff, 1998; Bachler and Neubuser, 2001). Shh signaling is required for patterning many regions of the skull, including the jaw and facial midline, and recent evidence suggest that this is a direct effect on NCCs (Jeong et al., 2004). Thus, multiple ectodermal signals converge on NCCs to control growth and patterning. NCCs also signal back to the overlying ectoderm to maintain ectodermal development (Creuzet et al., 2004).

In this study, we identify tfap2b as a pivotal factor in craniofacial skeletal development in zebrafish. tfap2b is expressed in the pharyngeal ectoderm, not in NCCs, and the combined loss of tfap2b and tfap2a function leads to defects in NCC-derived pharyngeal cartilages. Grafts of pharyngeal ectoderm into AP2-deficient embryos restores cartilage development. Taken together, these findings indicate that tfap2b and its close relative, tfap2a, play redundant roles in the ectoderm to control skeletogenesis of NCCs. This is the first in vivo demonstration of a requirement for AP2 transcription factors in the ectoderm, and strong evidence for redundant functions among AP2 family members.

Materials and methods

Animals and histology

Zebrafish embryos were obtained in natural crosses and staged according to Kimmel et al. (Kimmel et al., 1995). The lowts213 allele of tfap2a was originally isolated in the 1996 ENU mutagenesis screen in Tübingen (Schilling et al., 1996) and for this study was crossed into AB and fli1-GFP transgenic backgrounds (Lawson and Weinstein, 2002). low mutants were identified by their lack of early melanocytes at 25 hpf (Schilling et al., 1996; Knight et al., 2003). Cartilages were visualized by Alcian Blue staining and flat mounted (Kimmel et al., 1998; Javidan and Schilling, 2004).

Cloning and PCR amplification of tfap2b transcripts

Forward and reverse primers ap2b-7f (CGAGGCGAACGGACGGAGCG) and ap2b-1r (CCTTCACCACATAACACC) were designed to EST sequences fp02d11.y1 (GenBank Accession Number BG737469) and fp60d09.x1 (GenBank Accession Number BI671067), respectively. A 3.1 kb band corresponding to the full-length tfap2b (GenBank Accession Number DQ060246) was amplified by RT-PCR from 26 hpf embryos. This was cloned into pGEM T'Easy (Promega), completely sequenced in both directions using the Big Dye Terminator Sequencing reagent (ABI), and run on an ABI PRISM 310 sequencer (PE Applied Biosystems). RT-PCR amplification of tfap2b over exon 5 in morpholino-injected animals and for staging of tfap2b expression used 10 pmol each of primers ap2b-6f (AGAGCGGAGGTTTACTG) and ap2b-6r (ATGTGACATTCGCTGCC) with a slightly lower annealing temperature of 50°C for 30 seconds.

Whole-mount in situ hybridization and immunohistochemistry

In situ hybridization was carried out as described previously (Thisse et al., 1993). Antisense probe for tfap2b was synthesized with SP6 RNA polymerase from the amplified tfap2b clone following linearization by NcoI. Probes and antibodies used were dlx2 (Akimenko et al., 1994), hoxa2 (Prince at al., 1998), tfap2a and fgf8 (Furthauer et al., 1997), fli1 (Brown et al., 2000), gsc (Stachel et al., 1993), nkx2.3 (Lee et al., 1996), sef (Furthauer et al., 2002; Tsang et al., 2002), and sox9b (Li et al., 2002). Sectioning was performed after in situ hybridization. Embryos were immersed in 30% sucrose, embedded in 1% agar blocks, frozen in liquid nitrogen and cryostat sections cut at a thickness of 12 μm on a Leica cryostat.

Cell death detection assays

Apoptotic cell death was detected using a terminal transferase, dUTP nick-end labeling method (TUNEL) using several modifications suggested by the manufacturer (POD In Situ Cell Death Detection Kit, Roche). To avoid overfixing, embryos were dechorionated, and fixed in 4% PFA at 4°C overnight. They were then permeabilized with acetone at -20°C for 7 minutes and incubated in 2% goat serum at room temperature for 3 hours as a protein block prior to the TUNEL reaction. Apoptotic cells were counted in the pharyngeal region, between the posterior margin of the eye and anterior otic vesicle.

Morpholino injections

A morpholino ap2b-x5.1 (GCCATTTTTCGACTTCGCTCTGATC) was designed against the splice acceptor site of exon 5 in the tfap2b sequence at 1031 bp (Fig. 1B) by comparison with the corresponding genomic contig BX005121.8 from the zebrafish genome assembly (www.ensembl.org/D_rerio). The ap2b-x5.1 morpholino was reconstituted in 0.2M KCl and 3-5 ng was injected into one- or two-cell stage embryos together with 3% TRITC-dextran to act as a lineage tracer.

Ectoderm cell transplantation

Wild-type donor animals were injected with a combination of 3% TRITC-dextran (neutral, 10,000 Mr) and 3% biotin-dextran (lysine-fixable, 10,000 Mr) at the one- to two-cell stage. Cells within a few cell diameters of the animal pole were transplanted at the late blastula stage, as cell-tracing studies have shown that this region forms cranial ectoderm (Kimmel et al., 1990). Transplants in this position never formed endoderm or mesoderm, and were generally segregated in either non-neural ectoderm or in the neural tube and NCCs. Cells were transplanted into this location in low mutants and in wild-type siblings, and allowed to develop to 25 hpf, when transplanted cells were visualized by rhodamine fluorescence. Each embryo was then either: (1) fixed in 4% PFA and processed individually by in situ hybridization for sef expression, and detection of the biotin-labeled donor cells with a peroxidase coupled avidin-streptavidin complex (Vectastain) using DAB as the colored substrate; or (2) raised to 4 days postfertilization and processed for biotin detection and Alcian Blue staining for cartilage, as above.


Cloning and characterization of zebrafish tfap2b

We previously showed a requirement for tfap2a in NCC development (Knight et al., 2003; Knight et al., 2004), and here we have analyzed the expression and function of a zebrafish tfap2b. Two ESTs were identified by sequence comparison with mammalian Tcfap2b. A 3.1 kb fragment amplified from cDNA of 26 hpf embryos showed high similarity at the amino acid level to Tfap2b genes from chick, mouse and human (E<0) compared with Tfap2a genes from zebrafish (E<-141), mouse (E<-143) and human (E<-146), and was designated tfap2b. Alignment with other family members revealed that tfap2b shares the highly conserved DNA binding and heterodimerization domains characteristic of all AP2 proteins (data not shown). Zebrafish tfap2b genes are more similar in sequence to tfap2a (65%) than to tfap2g (60%), tfap2d (52%) or tfap2e (63%), and vertebrate Tfap2a and Tfap2b group together while Tfap2g is more distantly related (Fig. 1A).

Fig. 1.

Cloning and characterization of a zebrafish tfap2b. (A) Phylogenetic tree of AP2 genes shows zebrafish tfap2b more closely related to other vertebrate AP2b genes than to other zebrafish AP2 genes. Putative protein sequences of AP2 genes were aligned using ClustalX, edited by eye and used to generate a maximum likelihood tree by quartet puzzling using the PUZZLE program. Values at the nodes are likelihood values, showing support for that node out of 1000; branch lengths represent sequence divergence. (B) tfap2b contains the highly conserved transactivation (red), DNA-binding (blue) and heterodimerization domains (yellow) found in all AP2 proteins. Exon-intron boundaries are identical in tfap2a and tfap2b, and both have three alternative first exons (1a-c). A morpholino oligonucleotide directed against the splice acceptor site before exon 5 (ap2b-x5.1-'ap2bMO') should create a larger, unspliced product. (C) Splicing defects in tfap2b transcripts following ap2bMO injection. tfap2b was amplified from pools of ap2bMO-injected and control uninjected animals at 24 hpf using primers tfap2bf and tfap2br directed to exons 4 and 6, respectively. Uninjected animals showed PCR products of∼ 210 bp in size in comparison with ap2bMO-injected animals in which one larger product (∼424 bp) was observed because of aberrant splicing. (D) PCR amplification of tfap2b from RNA isolated from different stages of zebrafish gastrulation fails to detect expression before 10 hpf.

Using the whole zebrafish genome assembly (www.ensembl.org/Danio_rerio), we found that tfap2b has the same exon-intron arrangement as tfap2a, including exon-intron boundaries within the essential DNA-binding domain (Fig. 1B). To test tfap2b function during development, we designed an antisense morpholino (ap2bMO) to the splice acceptor site of tfap2b exon5 at 1030 bp in the mRNA sequence, an approach that we previously used successfully to disrupt tfap2a function (Knight et al, 2003). We used RT-PCR to show that injection of 5 ng ap2bMO per embryo disrupts splicing of tfap2b exon5 (Fig. 1C). We then sequenced the larger PCR product from ap2bMO-injected animals at 24 hpf and found that splicing failed at the intron-exon5 boundary, causing the intron to remain in the mRNA transcript. Similar splicing defects caused by a morpholino to tfap2a (ap2aMO) phenocopy the lockjaw mutant phenotype (Knight et al., 2003). The highly conserved exon-intron structures of AP2 genes, coupled with their nearly identical DNA binding and heterodimerization domains, suggests that the disruption of tfap2b splicing in ap2bMO-injected animals reflects a similar abrogation of tfap2b gene function as for tfap2a.

tfap2a and tfap2b are co-expressed in neural tube and ectoderm, but not neural crest

Unlike tfap2a, which is first expressed in the non-neural ectoderm during gastrulation and later in NCCs (Fig. 2A), tfap2b expression is first detected at six- to seven-somite stages in the hindbrain (Fig. 2B). Later, tfap2a is expressed throughout the surface ectoderm and in migrating NCCs, while tfap2b expression remains restricted to the hindbrain (Fig. 2C,D). Both genes are co-expressed in the developing intermediate mesoderm and by 24 hours postfertilization (hpf) in the pronephric ducts. tfap2b expression was not detected during gastrulation or early somitogenesis by in situ hybridization, or by RT-PCR on cDNA prepared from embryos harvested hourly between 6 and 10 hpf (Fig. 1D).

Surprisingly, tfap2b is not expressed in NCCs at any stage. Migrating NCCs in the pharyngeal arches express tfap2a at 24 hpf (Fig. 2E,G). At this stage, tfap2b is weakly expressed in the arches, but not in NCCs (Fig. 2F,H), and expression is restricted to surface pharyngeal ectoderm (see Fig. 6). By contrast, tfap2a is expressed in both NCCs and more broadly throughout the surface ectoderm. Its expression overlaps that of tfap2b in the diencephalon and rhombencephalon (Fig. 2E-H). These patterns of expression are maintained, with tfap2b expression restricted to a subset of tfap2a-expressing cells in the pharyngeal ectoderm (Fig. 2I,J). tfap2a and tfap2b are also co-expressed in the lens and retina (ganglion cell layer), midbrain (tectum and tegmentum), cerebellum and spinal cord. These expression domains persist until 52 hpf, whereas, by contrast, tfap2b mRNA is no longer detected in the pharyngeal ectoderm after 48 hpf (Fig. 2K,L).

Fig. 2.

Expression of tfap2a and tfap2b in early zebrafish embryos. Whole-mount in situ hybridization was performed with antisense RNA probes. Anterior is towards the left. (A,B) Lateral views at eight somites. (A) Expression of tfap2a in neural crest (nc) and non-neural ectoderm. (B) Hindbrain (hb) expression of tfap2b. (C,D) Lateral views, 18 somites. (C) tfap2a expression in migrating cranial NCCs, non-neural ectoderm (ec) and pronephric duct (pn). (D) tfap2b expression in the hindbrain and co-expression with tfap2a in the pronephric duct. (E,F) Lateral views of the head at 24 hpf showing co-expression of tfap2a and tfap2b in the forebrain, and in segmental cell groups in the hindbrain. (E) tfap2a expression in the pharyngeal NCCs (nc) and ectoderm (pe). (F) tfap2b expression in the ectoderm of arches 1 and 2. (G,H) Dorsal views, 24 hpf. (G) tfap2a expression in the CNS, including rhombomeres (r3 and r4) and in pharyngeal NCCs and ectoderm. (H) tfap2b expression in rhombomeres of the hindbrain and in pharyngeal ectoderm, but not in NCCs. (I,J) Lateral views, 36 hpf. tfap2a and tfap2b co-expression in the optic tectum (ot) and tegmentum of the midbrain and hindbrain, and in the pharyngeal ectoderm. Only tfap2a is expressed in NCCs. (K,L) Lateral views, 52 hpf. tfap2a and tfap2b co-expression in the midbrain and hindbrain, and in the ganglion cell layer of the retina. Only tfap2a is expressed in the pharyngeal arches, lateral line organs (la) and in the apical ectoderm of the pectoral fins (pf). Scale bars: in A, 100 μm for A-D; in E, 100 μm for E-L.

tfap2a and tfap2b are both required for craniofacial development

To test tfap2b function, 3 ng/embryo of ap2bMO was injected into wild-type embryos at the one- to two-cell stage. This effectively blocked splicing of the tfap2b transcript (Fig. 1C) and injected embryos appeared healthy at 72 hpf (Fig. 3A,C). This was also true for injections of 5-10 ng/embryo. By contrast, injection of 3 ng/embryo of ap2bMO into low mutants (hereafter referred to as `AP2a/b-deficient') caused more severe craniofacial defects than low alone. In low mutants, the jaw hangs ventrally and the hyoid and branchial arches are reduced (Fig. 3B). By contrast, AP2a/b-deficient embryos lack virtually all pharyngeal cartilages (Fig. 3D). low mutant embryos were distinguished from ap2bMO-injected wild-type siblings by a lack of melanocytes at 26 hpf. This was further confirmed by PCR identification from tail DNA of ap2bMO-injected mutants using a restriction site created by the low lesion in exon 5 of tfap2a (data not shown) (Knight et al., 2003).

Closer examination of cartilage confirmed that ap2bMO has no effect in the presence of a functional tfap2a gene. In low mutants alone, both dorsal (hyosymplectic, hs) and ventral (ceratohyal, ch) hyoid cartilages are reduced, and remnants of the hyoid fuse with the mandibular arch (Fig. 3F). By contrast, AP2a/b-deficient larvae also lack an anterior neurocranium and much of the mandibular arch (Fig. 3H). The posterior neurocranium and pectoral fin skeletons, which are derived from mesoderm, are not affected. Rather, defects are restricted to NCC-derived cartilage, suggesting that tfap2a and tfap2b play redundant roles in the development of skeletogenic NCCs.

tfap2b is not required for early neural crest cell specification

To determine if tfap2b, like tfap2a, is required during early NCC development, we examined dlx2 and hoxa2 expression in the pharyngeal arches. At 26 hpf, dlx2 expression marks migrating NCCs in mandibular, hyoid and branchial NCCs (m, h and b in Fig. 4A). hoxa2 is co-expressed in hyoid and branchial NCCs (Fig. 4D). Both are reduced in the hyoid arch to a few ventral cells in low mutants. By contrast, mandibular expression of dlx2 is unaffected (Fig. 4A,B) (Knight et al., 2003). ap2bMO injections into low mutant embryos did not enhance this phenotype (Fig. 4C,F) or disrupt dlx2 or hoxa2 expression (data not shown). Thus, unlike tfap2a, tfap2b is not required for early homeobox gene activation in NCCs.

To test later requirements for tfap2b in the arches, we examined expression of the ETS-domain transcription factor fli1 in AP2a/b-deficient embryos (Brown et al., 2000). fli1 is first expressed in NCCs at 22 hpf, after migration, and also in vascular endothelia (Fig. 4G-I). In low mutants, fli1 expression is slightly reduced in the hyoid and branchial arches (Fig. 4H), but not in the mandibular arch, similar to dlx2. Injection of up to 5 ng of ap2bMO had no effect on fli1 expression in wild-type controls (data not shown). However, ap2bMO nearly eliminated fli1 expression in the arches when injected into low mutants (Fig 4I). These results are consistent with a requirement for tfap2b in NCCs after migration into the arch primordia.

tfap2b regulates patterns of cartilage condensation

To address requirements for tfap2b in skeletogenic NCCs, we examined goosecoid (gsc) and sox9a expression (Fig. 4J-O). Both genes play important roles in skeletal differentiation (Rivera-Perez et al., 1999). gsc expression is reduced in the dorsal hyoid arch in low mutants, and this correlates with loss of hoxa2 expression and hyosymplectic cartilage. Expression in the ventral arch is unaffected (Fig. 4K) (Knight et al, 2003). Injection of up to 5 ng of ap2bMO has no effect on gsc expression (data not shown). However, in AP2a/b-deficient embryos, gsc expression is eliminated throughout the hyoid (Fig. 4L). This suggests that tfap2b is required for the specification of NCC skeletal progenitors.

Fig. 3.

Jaw and pharyngeal cartilage defects in low mutants and in larvae injected with ap2bMO. Lateral views (A-D) of live larvae show reduced head size and jaw defects (arrows) in AP2-deficient animals at 4 dpf. (E-H) Dissected pharyngeal cartilages from 4 dpf shown in ventral view. Pharyngeal cartilages are absent or reduced in all but the mandibular arch in low mutants (F), and fuse with the anterior basicranial commissure of the skull. The neurocranium (asterisks) is typically not affected. (G) Injection of ap2bMO alone has no effect, but injection into low (H) causes loss of both pharyngeal and neurocranial cartilage. The posterior neurocranium remains intact. cb, ceratobranchial; ch, ceratohyal; hs, hyosymplectic; m, Meckel's cartilage; n, notochord; pc, parachordals; pq, palatoquadrate. Scale bars: 100 μm.

Fig. 4.

Defects in pharyngeal arch development in low mutants and in larvae injected with ap2bMO. Whole-mount in situ hybridization with riboprobes to dlx2 (A-C; 28 hpf), hoxa2 (D-F; 28 hpf), fli1 (G-I; 28 hpf), gsc (J-L; 40 hpf) and sox9a (M-O; 52 hpf). (A-L) All embryos are shown in lateral view, except M-O, which are ventral views. Wild-type (A,D,G,J,M), low (B,E,H,K,N) and injected low mutants (C,F,I,L,O). Arrowheads in G-I indicate vascular expression of fli1. Arrows in J-L indicate the hyosymplectic condensation in the dorsal second arch. Asterisks in M-O indicate the mouth. All five NCC markers are reduced in the second pharyngeal arch in low mutants, but only fli1, gsc and sox9a defects are enhanced by Tfap2b depletion (L,P,T). b, branchial arches; h, hyoid arch; hb, hindbrain; m, mandibular arch; n, notochord. Scale bars: 100 μm.

Unlike low/tfap2a-/- mutants alone, AP2-deficient embryos also show defects in the neurocranium. Two clusters of cartilage precursors in the pharyngeal arches, and a third pair dorsal to the mouth that form the neurocranium, express sox9a at 52 hpf (Fig. 4M). low mutants lack sox9a expression in the hyoid, and mandibular domains remain split at the midline, but do not affect the neurocranium (Fig. 4N). ap2bMO injections alone have no effect on the neurocranium (data not shown), but cause a complete loss of neurocranial sox9a expression when injected into low (Fig. 4O). These results demonstrate requirements for AP2 function throughout the NCCs that form the neurocranium and pharyngeal arches.

We used a transgenic line in which the fli1 promotor drives eGFP (fli1-GFP), to correlate NCC and skeletal defects (Lawson and Weinstein, 2002). This fli1-GFP transgene was crossed into lowts213 and used to visualize NCCs in the pharyngeal arches of 36 hpf individuals, that were then raised to 4 dpf and stained for cartilage (Fig. 5). In this line, the fli1-GFP co-localizes with dlx2 expression in NCCs (data not shown). fli1-GFP expression was reduced in low mutants (Fig. 5E) and much more severely reduced in AP2a/b-deficient embryos at 36 hpf (Fig. 5F).

Fig. 5.

Cartilage defects correlate with postmigratory NCC defects in low mutants and larvae injected with ap2bMO. Columns consist of photos taken at different stages in the same animal. Lateral views of living fli1-GFP transgenic embryos at 28 hpf (A-F) and cartilage preparations from the same individuals at 4 dpf (G-I). fli1-GFP expression includes both NCC as well as developing endothelial cells. Arrows in F indicate residual NCCs. b, branchial arches; cb, ceratobranchial; ch, ceratohyal; h, hyoid arch; hs, hyosymplectic; m, mandibular arch; mc, Meckels cartilage; n, notochord; pc, parachordals; pq, palatoquadrate. Scale bars: 100 μm.

Fig. 6.

tfap2a and tfap2b are co-expressed in the ectoderm, but only tfap2a is expressed in pharyngeal arch NCCs. Transverse cryosections through the pharyngeal region of embryos at 26 hpf (A-C) and 36 hpf (D-F) labeled by in situ hybridization with riboprobes to dlx2 (A,D), tfap2a (B,E) and tfap2b (C,F). Left side views, with the pharyngeal lumen, neural tube and notochord at the midline lying to the right. Arrowheads in D indicate unlabeled surface ectoderm. Scale bars: 50μ m.

We observed a range of defects in fli1-GFP expression in low mutants and AP2a/b-deficient embryos. Severely affected mutants have weak neurocranial defects (e.g. reduction of the ethmoid plate) and a complete lack of hyoid cartilage, and these correlate with reduced fli1-GFP expression in NCCs (Fig. 5E,H). fli1-GFP expression persists in the mandibular arch in low mutants. By contrast, AP2a/b-deficient embryos lack GFP expression, with only small patches of expression remaining adjacent to the stomodeum and first pharyngeal pouch (Fig. 5F), and these fish completely lack mandibular and neurocranial cartilages (Fig. 5I). These results show that the cartilage defects caused by ap2bMO injection arise in their precursors in postmigratory NCCs.

tfap2a and tfap2b promote survival of pharyngeal ectoderm

tfap2a is required cell autonomously in NCCs (Knight et al., 2003), and in mice Tcfap2a directly regulates hoxa2 transcription in NCCs (Maconochie et al., 1999). By contrast, zebrafish tfap2b is not expressed in NCCs, yet both tfap2a and tfap2b are required in the NCC-derived skeleton. The only tissue likely to account for this redundancy is the cranial ectoderm, as tfap2a is expressed throughout this ectoderm and tfap2b is expressed locally in a small patch of pharyngeal ectoderm at 20 hpf. Sections of embryos at both 24 and 36 hpf, labeled by whole-mount in situ hybridization prior to sectioning, reveal that tfap2a is expressed in both NCCs and ectoderm (Fig. 6B), and overlaps in NCCs with dlx2 expression (Fig. 6A). By contrast, tfap2b expression is restricted to ectoderm (Fig. 6C). These results suggest that tfap2b function is required in the pharyngeal ectoderm, and redundant with that of tfap2a.

Do AP2a/b-deficient embryos have defects in pharyngeal ectoderm? AP2 proteins play important roles in cell survival, and Tcfap2a mutant mice show elevated apoptosis. We examined apoptosis in the ectoderm using TUNEL labeling (Fig. 7A-I). In the lowts214 allele of tfap2a, a brief period of apoptosis occurs in NCCs between 10 and 14 somites (Knight et al, 2003), and apoptosis is more widespread in the mob610 allele (Barallo-Gimeno et al., 2004). We performed TUNEL labeling in either low mutants alone (Fig. 7B,E,H) or AP2a/b-deficient embryos (Fig. 7C,F,I) carrying the fli1-GFP transgene. Colocalization of GFP and TUNEL showed that apoptosis was excluded from NCCs, and confined to the ectoderm. The number of TUNEL labeled cells in pharyngeal ectoderm at 28 hpf was similar in low mutants (4.5±2.62; n=4) and wild-type controls (4.3±2.32; n=6), and only slightly increased in embryos injected with the ap2b MO alone (7.3±4.49; n=5). By contrast, TUNEL labeling was dramatically elevated in AP2a/b-deficient embryos (75.8±16.22; n=6). Large numbers of apoptotic NCCs were observed along the dorsal edges of the spinal cord in the tail, and this correlates with pigment cell defects in the tail in low mutants (Fig. 7G-I) (Knight et al, 2004). Elevated ectodermal apoptosis was observed not only in the pharyngeal arches in AP2-deficient animals, but also in olfactory epithelia and in the skin overlying the hindbrain (data not shown).

By contrast, other epithelia such as the pharyngeal endoderm are unaffected by the loss of AP-2. The NK homeobox gene, nkx2.3, marks the pharyngeal pouch endoderm at 34 hpf (Fig. 7J), and this endoderm forms a normal series of pouches in low mutants and in AP2a/b-deficient embryos (Fig. 7K,L).

Fig. 7.

Defects in ectodermal specification and survival in low mutants and in larvae injected with ap2bMO. (A-I) TUNEL labeling of apoptotic cells at 28 hpf is shown in lateral views of the head (A-F) and tail (G-I). (D-F) Co-labeling with TUNEL and the fli1-GFP transgene showing apoptosis lateral to the NCCs in the surface ectoderm (arrows). (J-L) In situ hybridization for nkx2.3 at 28 hpf in dorsal view. Expression is detected in pharyngeal ectoderm and endodermal pouches (arrowheads). b, branchial; h, hyoid; m, mandibular; mf, median fin; n, notochord; ot, otic vesicle; sc, spinal cord. Scale bars: 100 μm.

Fig. 8.

Transplants suggest that tfap2a and tfap2b are required in the pharyngeal ectoderm, and act non-autonomously in NCCs. Each column represents photos taken at different stages of the same animal. Columns 1 and 2 show transplants from wild-type donors into low mutant hosts, whereas the host in column 3 is a low mutant injected with ap2bMO. Prospective cranial ectodermal cells were transplanted from donor embryos labeled with a lineage tracer into unlabeled hosts at 4-5 hpf (A). Lateral views of living mosaic embryos at 28 hpf (A-G) showing that transplanted cells (red rhodamine-labeled cells in E-G) form patches of ectoderm covering parts of the face and arches. (H,I) Ventral views of mosaic larvae at 4 dpf stained for biotinylated lineage tracer (brown) in the ectoderm. Arrows in H indicate transplanted donor cells in ectoderm. Arrowheads in H,I indicate rescued cartilage of the ceratohyal. (J) fli1-GFP expression in the same embryo as G. (K,M) Flat-mounted rescued cartilages (blue) with ectoderm attached (brown). (L) Higher magnification view of the larvae shown in I, in which transplanted ectodermal cells and cartilage can be clearly distinguished. (O) Section through rescued ceratohyal cartilage in K. (N,P) Diagrams of cartilages shown in K and M. cb, ceratobranchial; ch, ceratohyal; e, ethmoid; h, hyoid arch; hs, hyosymplectic; m, mandibular arch; mc, Meckel's cartilage; ot, otic vesicle; pc, parachordals; pq, palatoquadrate; se, surface ectoderm; t, trabeculae. Scale bars: 50 μm.

Ectodermal grafts rescue AP2-dependent cartilages

To determine if tfap2a and tfap2b are required in ectoderm, we performed transplants. Ectodermal precursors were transplanted at blastula stages, from fluorescently labeled wild-type donor embryos [injected with tetramethylrhodamine (TRITC) and biotin-conjugated dextrans], into unlabeled low mutants injected with ap2bMO (Fig. 8A). Cells placed near the animal pole gave rise to scattered clones in the skin of the head at later stages. Transplanted cells contributed to the olfactory epithelia (n=34; Fig. 8E), retina (n=36; Fig. 8F,G) and neural tube (n=6), as well as the pharyngeal ectoderm (n=14; Fig. 8E-G), but not to the mesoderm or endoderm. Of 14 low mutant hosts with transplanted wild-type pharyngeal ectoderm, four showed unilateral rescue of hyoid arch development coinciding with the transplanted cells (Fig. 8, left and center columns). Similar rescues were achieved in 5/9 transplants of pharyngeal ectoderm into low mutants injected with ap2bMO (Fig. 8, right column), and in these cases we also observed rescue of fli1-GFP expression on the transplanted side (Fig. 8J). Transplanted cells were clearly situated in the ectoderm when TRITC was compared with fli1-GFP (compare Fig. 8G and 8J) and later biotin-labeling compared with cartilage at 4 dpf (Fig. 8H,I). In each case, either the ceratohyal, hyosymplectic or ceratobranchial cartilages (or in some cases all three) were rescued on one side adjacent to transplanted ectodermal cells (Fig. 8K-P). In some cases, transplants also rescued more dorsal defects in the neurocranium, indicating that the ectoderm also influences these cartilages. This demonstrates that tfap2a and tfap2b are required non-autonomously in the ectoderm to regulate NCC-derived cartilage differentiation, in addition to the well-documented, cell-autonomous roles of tfap2a in NCCs.

AP2 regulates Fgf signaling from the ectoderm

What ectodermal signal is disrupted in AP2a/b-deficient embryos? Shh, Bmp4 and Fgf8 are expressed in the facial ectoderm, and all three have been implicated in NCC patterning, proliferation and survival (Bachler and Neubeuser, 2001). tfap2a mutants lack Shh expression in the posterior ectoderm of the hyoid arch (Knight et al., 2003), but injection of ap2b-MO into low mutants does not cause any defects in shh expression. Likewise, bmp4 expression is only slightly reduced in the ventral ectoderm in AP2a/b-deficient embryos (data not shown). To address requirements for AP-2 in regulating Fgfs, we examined fgf3 and fgf8 expression, both of which have been implicated in craniofacial development in zebrafish (Roehl and Nusslein-Volhard, 2001; David et al., 2002). fgf8 is expressed in the mandibular ectoderm and more weakly in more posterior arch ectoderm at 28 hpf. Expression of both fgf3 and fgf8 persists in AP2a/b-deficient embryos (Fig. 9A,B).

Other Fgf proteins (Fgf9, Fgf17 and Fgf18) expressed in cranial ectoderm in mammals have not been well characterized in zebrafish. Therefore, we examined expression of the interleukin receptor-related Fgf target sef as a general indicator of responses to Fgfs in the arches. sef is expressed in cranial NCCs in the arches beginning at 18 hpf, and near other sources of Fgfs at the mid-hindbrain boundary and in the pectoral fin buds (Fig. 9C). Expression of sef is lost in the first arch (mandibular) and strongly reduced in the second arch (hyoid) in AP2a/b-deficient embryos, while other domains of expression are unaffected (Fig. 9D). This appears to reflect a loss of Fgf produced by the ectoderm, as transplantation of wild-type pharyngeal ectoderm partially rescues sef expression on the grafted side (8/18; Fig. 9E). Our results implicate Fgfs as one component of the ectodermal signals that require the combined functions of Tfap2a and Tfap2b.

Fig. 9.

tfap2a and tfap2b are required for Fgf signaling in NCCs. Lateral views, anterior towards the left. (A,B) At 32 hpf, fgf8 mRNA is detected in wild type in the ectoderm covering the arches, in addition to the mid-hindbrain boundary (mhb); this expression remains in AP2a/b-deficient embryos. Arrows in A,B indicate ectodermal expression of fgf8. (C,D) At 28 hpf in wild type, sef mRNA is detected in NCCs; this expression is severely reduced in AP2a/b-deficient embryos. (E,F) Mosaic embryos in which biotin-labeled, wild-type ectodermal cells (brown, arrows) were transplanted on one side of the head and partially restore sef expression (blue). (E) Dorsal view, anterior towards the left showing transplanted side with substantially increased levels of sef expression, and lack of expression on the contralateral, control side (arrows). (F) A transverse section through the embryo shown in E at the level of the hyoid arch showing grafted wild-type ectoderm (brown) and rescued sef expression in underlying NC (blue). Arrowhead in F indicates transplanted ectoderm. m, mandibular arch; h, hyoid arch; b, branchial arches. Scale bars: 50 μm.


We have identified a zebrafish tfap2b required for craniofacial development that acts together with tfap2a in the pharyngeal ectoderm to promote skeletal development of NCCs. Two lines of evidence lead to these conclusions: (1) tfap2b is expressed in the ectoderm, but not in NCCs, yet it functions redundantly with tfap2a in cartilage development; (2) transplantation of wild type ectoderm into an AP2a/b-deficient embryo partially rescues NCC-derived cartilage. Based on our morpholino studies, tfap2b is not required for early NCC specification, but only later after migration. We propose that AP2 genes act in two separate aspects of NCC development (Fig. 10). First, tfap2a regulates specification of skeletal precursor cells and their segmental identities, through regulation of Hox group 2 genes (Knight et al., 2003). Second, tfap2a and tfap2b together control Fgfs and perhaps other signals from the ectoderm that regulate skeletogenesis. The coordinated action of these pathways mediates the spatiotemporal formation of craniofacial cartilage and bone.

Redundancies between tfap2a and tfap2b

In mice, Tcfap2a and Tcfap2b are co-expressed in many embryonic tissues such as NCCs, yet have unique requirements in development. Loss-of-function mutations in Tcfap2a disrupt neural tube closure and craniofacial NCCs (Schorle et al., 1996; Zhang et al., 1996). By contrast, mutations in Tcfap2b or human TFAP2B, cause renal failure and craniofacial defects associated with Char syndrome (Moser et al., 1997b; Satoda et al., 2000). AP2 proteins may function redundantly in tissues where they are co-expressed, and our results support this hypothesis for the ectoderm (Moser et al., 1997a). Zebrafish tfap2b is only co-expressed with tfap2a in a restricted domain within the pharyngeal ectoderm. Few studies have addressed AP2 functions in ectoderm as the skin appears to develop normally in Tfap2a-/- and Tfap2b-/- mutant mice (Schorle et al., 1996). Disruption of tfap2b alone has no effect on zebrafish embryos, but enhances defects in ectodermal cell survival and craniofacial cartilage caused by loss of tfap2a alone, suggesting that the two AP2 proteins can compensate for one another. tfap2a and tfap2b are also co-expressed in the pronephric ducts, and in several regions of the CNS, where they may also be redundant.

Fig. 10.

Model depicting proposed cell autonomous and non-autonomous roles for AP2 proteins in NCC development. Illustrations of transverse sections depicting early migratory stages of NCCs (A) and later interactions within the pharyngeal primordia (B). (A) Initially, tfap2a acts autonomously within NCCs to regulate hoxa2, dlx2 and kit expression. (B) Later, tfap2a and tfap2b act together in the surface ectoderm (blue) to regulate Fgf8 and possibly other Fgfs that activate sef expression and control cartilage development, together with Fgf3 signaling from the pharyngeal endoderm (yellow).

Separate requirements for AP2 genes in early versus late NCC development

tfap2a promotes Hoxa2 expression in NCCs that populate the hyoid arch (Maconochie et al., 1999; Knight et al., 2003; Knight et al., 2004). hoxa2 expression may similarly be activated by tfap2b, which shares nearly identical DNA-binding domains and binds a NCC-specific Hoxa2 enhancer, albeit with different affinity (Maconochie et al., 1999). To address this issue in NCCs, we morpholino-depleted tfap2b from low (tfap2a) mutants, examined hoxa2 mRNA, and found that the loss of tfap2b had no effect. This suggests that tfap2b does not compensate for tfap2a in activating hoxa2, but only later in cartilage induction. Our data also argue against a role for AP2 genes in NCC migration. NCCs migrate into all of the arches in the low allele of tfap2a (Knight et al., 2003), though some cells fail to migrate into the hyoid arch in the mob610 allele (Barrallo-Gimeno et al., 2004) and we show that depletion of Tfap2b protein in low does not enhance defects in early markers of migrating NCCs such as hoxa2 and dlx2.

Rather, we argue that tfap2b regulates NCC specification after migration into the arches as cells condense to form cartilage. In contrast to hoxa2, expression of fli1 is reduced in AP2a/b-deficient embryos, compared with low alone, and we used a fli1-GFP transgene to show that this prefigures condensation defects. Later markers of differentiating cartilage, such as gsc and sox9a, are almost completely eliminated in these embryos. Surprisingly, AP2a/b-deficient embryos also have defects in the neurocranium. As both pharyngeal and neurocranial cartilages derive from NCCs (the posterior head skeleton is mesodermal) these results suggest that AP2 genes are required for the development of other NCC-derived cartilages. tfpa2a and tfap2b may be partially redundant in more anterior cartilages of the mandibular arch and neurocranium, which are not disrupted in tfap2a-/- mutants alone.

Separate requirements for AP2 genes in NCCs and in surface ectoderm

Tcfap2a is required cell-autonomously for NCC specification, prior to migration into the pharyngeal arches (Knight et al., 2003; Knight et al., 2004), and directly regulates hoxa2 and kit transcription (Maconochie et al., 1999). Here, we show an additional non-autonomous requirement for AP2 proteins in the pharyngeal ectoderm. To achieve this, we grafted ectodermal precursors from wild-type donors into either low or AP2a/b-deficient embryos and analyzed the cartilage pattern. Grafts that included pharyngeal ectoderm rescued cartilage unilaterally on the transplanted side, including restoration of dorsal first (palatoquadrate) and second (hyosymplectic) arch cartilages, as well as their separation from the neurocranium. This is a dramatic example of a non-autonomous role for ectoderm in cartilage development and is consistent with previous studies in mice implicating the surface ectoderm in arch patterning (Trumpp et al., 1999; Trokovic et al., 2003; Macatee et al., 2003). A non-autonomous requirement for tfap2a has previously been suggested for NCC-derived melanocytes (O'Brien et al., 2004). These requirements in ectoderm appear to act separately and in parallel to chondrogenic signals from the pharyngeal endoderm (Hall, 1980; David et al., 2002), and AP2-deficient embryos show no defects in endoderm.

Ectodermal signals may also regulate Hox gene expression in the arches and arch identities. Cartilage defects in low (tfap2a) mutant zebrafish resemble homeotic defects caused by loss of Hox group 2 gene function, in which hyoid cartilages are transformed to a mandibular fate (Knight et al., 2004). This could be caused directly by loss of Hoxa2 transcriptional activation by AP2 proteins in NCCs, or indirectly by defects in surrounding tissues. Our results indicate both direct and indirect roles for tfap2a, as ectodermal grafts rescue cartilage formation as well as homeotic transformations of the hyoid skeleton in low mutant embryos (Knight et al., 2004). This suggests that Hox genes initially specify the segmental identities of migrating NCCs, but then require ectodermal signals to maintain this identity (Trainor and Krumlauf, 2000; Schilling et al., 2000). Defects in Hoxa2-/- mutant mice have been interpreted as intrinsic changes in NCC, but Hoxa2 expression is lost in both ectoderm and NCCs, and the role of the ectoderm has been largely ignored. In Hoxa2 mutants, ectopic expression of mandibular arch genes in the hyoid arch results from defects in reciprocal signals between NCCs and ectoderm (Bobola et al., 2003). Our results suggest that the ectoderm maintains Hox expression in NCCs during migration, and this depends on AP2 genes.

Tcfap2a expression begins during gastrulation in the non-neural ectoderm and persists in the skin throughout embryonic development. We show that AP2-deficient zebrafish have defects in ectodermal survival. Tcfap2a promotes ectoderm formation in Xenopus (Luo et al., 2002; Luo et al., 2003) and regulates genes involved in epidermal differentiation in mammals (Pfisterer et al, 2002; Zhang et al, 1996; Schorle et al, 1996). In contrast to tfap2a, however, which is expressed broadly in the ectoderm, tfap2b expression is restricted to the pharyngeal ectoderm, and it is here that we find elevated apoptosis by TUNEL labeling in AP2a/b-deficient embryos. We previously described a wave of early apoptosis in the premigratory NCCs and overlying ectoderm in low mutants at neurula stages (Knight et al., 2003) and death is even more extensive in the pharyngeal arches of the mob610 allele of tfap2a (Barrallo-Gimeno et al., 2004). Apoptosis in the NCCs is considered to be the causative phenotype for mouse Tcfap2a mutants, implying that AP2 genes function cell-autonomously in NCC survival (Hilger-Eversheim et al., 2000; Decary et al., 2002), but we have not observed extensive death in NCCs in AP2-deficient zebrafish, only ectoderm.

AP2, Hoxa2 and Fgf signaling

Many growth factors (e.g. Fgf8, Shh, Bmp4, etc.) are expressed in pharyngeal ectoderm and have been implicated in craniofacial development (Wall and Hogan, 1995). Our results suggest that one component of the ectodermal signal to NCCs is an Fgf, but probably not Fgf8. Expression of the Fgf-responsive gene sef, is disrupted in AP2a/b-deficient embryos, and can be partially rescued by grafts of wild-type ectoderm. Several Fgfs are expressed in the pharyngeal ectoderm, including Fgf8 and Fgf17 (Reifers et al., 2000). However, fgf8 mRNA appears unaffected in AP2a/b-deficient zebrafish embryos. We have previously shown that tfap2a is also required for shh expression in the posterior ectodermal margin of the hyoid arch (Knight et al., 2004). Thus, in the hyoid arch, AP2 proteins may simultaneously regulate Shh and Fgf signals from the pharyngeal ectoderm that control skeletal growth and pattern.

Fgf8 seemed the most likely candidate to be regulated in the ectoderm, because it is required for mandibular development in the mouse (Trumpp et al., 1999; Abu-Issa et al., 2002). Macatee et al. (Macatee et al., 2003) used Cre-lox mediated removal of Fgf8 in the pharyngeal ectoderm to demonstrate an ectodermal requirement in mice. These animals lacked mandibular arches and more posterior arches were fused. By contrast, fgf3 is required in the endoderm for formation of the posterior, branchial arch skeleton, but appears to play less of a role in the mandibular and hyoid (David et al., 2002) and we have not detected any defects in fgf3 expression in AP2a/b-deficient embryos. Both fgf3 and fgf8 in zebrafish play a role in endodermal pouch formation, and the combined disruption of both leads to severe reductions in the cranial skeleton (Walshe and Mason, 2003; Crump et al., 2004). Likewise, a hypomorphic mutation in Fgfr1 in the facial ectoderm in mice eliminates the hyoid arch skeleton but not the mandibular arch, similar to low/tfap2a mutant zebrafish (Trokovic et al., 2003), suggesting that Fgfs expressed in the ectoderm autoregulate their own expression and subsequent signaling to adjacent NCCs.

Interestingly, Fgf signaling in the mouse has been proposed to inhibit Hoxa2 expression in mandibular arch NCCs, suggesting that this may be a convergence point for AP2 and Fgf functions in establishing pharyngeal arch identity. Hoxa2 represses Fgf activated genes such as Pitx1 and Lhx6 in NCCs of the hyoid arch (Bobola et al., 2003). In Hoxa2-/- mutants, these genes are ectopically expressed and the hyoid arch is transformed to a mandibular fate. We previously described similar transformations in low mutant zebrafish. Our data suggest that these are due to an early function for tfap2a in regulating the expression of hoxa2 directly in NCCs, while a tfap2b-dependent signal from the ectoderm (possibly an Fgf) is involved only later in chondrogenesis.

Conserved functions for AP2 transcription factors in vertebrate development

NCCs arose at the origin of vertebrates and many of the genes involved in NCC patterning evolved from ancestral genes that had more ancient roles in patterning other tissues. In the invertebrate chordate, amphioxus, an AP2 gene is expressed in the non-neural ectoderm, indicating that this is a conserved feature of AP2 genes in all chordates (Meulemans and Bronner-Fraser, 2002). Pharyngeal arches also have an origin prior to that of the NCCs, as evidenced by the presence of branchial gills in amphioxus and appendicularian urochordates. The pharyngeal arches are initially patterned independently of NCCs as shown by NCC extirpations in the chick, in which ectodermal and endodermal patterning is not perturbed (Veitch et al., 1999). Given that AP2 genes have ancient roles in patterning of the ectoderm and that pharyngeal arches arose prior to the NCCs, it is tempting to speculate that AP2 genes were involved in patterning the pharyngeal ectoderm prior to the origin of NCCs. Thus, when NCCs first gained their migratory behavior, they retained some of their identity from their site of origin in the hindbrain through NCC-specific genes, such as tfap2a, but were influenced by signals already present in the arch environment into which they migrated, including those regulated by AP2.


We thank T. Williams and I. Blitz for stimulating discussions, as well as K. Cho, I. Blitz, and members of our laboratory for critical reading of the manuscript. We also thank B. Weinstein for the kind gift of the fli1-GFP transgenic strain and the following people for fish and probes: C. Kimmel, V. Prince and D. Stemple. This work was supported by the NIH (NS-41353, DE-13828), March of Dimes (1-FY01-198) and Pew Scholars Foundation (2615SC) to T.S.


    • Accepted April 26, 2005.


View Abstract